216 related articles for article (PubMed ID: 3907362)
1. Leu-M1 antigen expression in T-cell neoplasia.
Wieczorek R; Burke JS; Knowles DM
Am J Pathol; 1985 Dec; 121(3):374-80. PubMed ID: 3907362
[TBL] [Abstract][Full Text] [Related]
2. Leu-M1--a marker for Reed-Sternberg cells in Hodgkin's disease. An immunoperoxidase study of paraffin-embedded tissues.
Pinkus GS; Thomas P; Said JW
Am J Pathol; 1985 May; 119(2):244-52. PubMed ID: 3887932
[TBL] [Abstract][Full Text] [Related]
3. Leu-M1 antigen expression in advanced (tumor) stage mycosis fungoides.
Wieczorek R; Suhrland M; Ramsay D; Reed ML; Knowles DM
Am J Clin Pathol; 1986 Jul; 86(1):25-32. PubMed ID: 3088980
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies in the diagnosis of Hodgkin's disease. The search for a rational panel.
Chittal SM; Caverivière P; Schwarting R; Gerdes J; Al Saati T; Rigal-Huguet F; Stein H; Delsol G
Am J Surg Pathol; 1988 Jan; 12(1):9-21. PubMed ID: 2827535
[TBL] [Abstract][Full Text] [Related]
5. The spectrum of Leu-M1 staining in lymphoid and hematopoietic proliferations.
Swerdlow SH; Wright SA
Am J Clin Pathol; 1986 Mar; 85(3):283-8. PubMed ID: 2428238
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte and HLA-D region specific monoclonal antibodies in the diagnosis of Hodgkin's disease.
Norton AJ; Isaacson PG
J Clin Pathol; 1985 Nov; 38(11):1241-6. PubMed ID: 3864794
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies reactive in routinely processed tissue sections of malignant lymphoma, with emphasis on T-cell lymphomas.
Strickler JG; Weiss LM; Copenhaver CM; Bindl J; McDaid R; Buck D; Warnke R
Hum Pathol; 1987 Aug; 18(8):808-14. PubMed ID: 3301626
[TBL] [Abstract][Full Text] [Related]
8. Bauhinia purpurea--a new paraffin section marker for Reed-Sternberg cells of Hodgkin's disease. A comparison with Leu-M1 (CD15), LN2 (CD74), peanut agglutinin, and Ber-H2 (CD30).
Sarker AB; Akagi T; Jeon HJ; Miyake K; Murakami I; Yoshino T; Takahashi K; Nose S
Am J Pathol; 1992 Jul; 141(1):19-23. PubMed ID: 1352944
[TBL] [Abstract][Full Text] [Related]
9. Utility of combining antigranulocyte with antileukocyte antibodies in differentiating Hodgkin's disease from non-Hodgkin's lymphoma.
Medeiros LJ; Weiss LM; Warnke RA; Dorfman RF
Cancer; 1988 Dec; 62(12):2475-81. PubMed ID: 2973368
[TBL] [Abstract][Full Text] [Related]
10. Immunopathology of cutaneous T-cell lymphomas.
Nasu K; Said J; Vonderheid E; Olerud J; Sako D; Kadin M
Am J Pathol; 1985 Jun; 119(3):436-47. PubMed ID: 3893149
[TBL] [Abstract][Full Text] [Related]
11. Leu M1 and S100 in Hodgkin's disease and non-Hodgkin's lymphomas.
Kornstein MJ; Bonner H; Gee B; Cohen R; Brooks JJ
Am J Clin Pathol; 1986 Apr; 85(4):433-7. PubMed ID: 3754087
[TBL] [Abstract][Full Text] [Related]
12. Utility of Leu M1 monoclonal antibody in the differential diagnosis of Hodgkin's disease.
Hyder DM; Schnitzer B
Arch Pathol Lab Med; 1986 May; 110(5):416-9. PubMed ID: 3516118
[TBL] [Abstract][Full Text] [Related]
13. Coexisting Hodgkin's disease and mycosis fungoides. Immunohistochemical proof of its existence.
Simrell CR; Boccia RV; Longo DL; Jaffe ES
Arch Pathol Lab Med; 1986 Nov; 110(11):1029-34. PubMed ID: 3096258
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody Leu-22 (L60) permits the demonstration of some neoplastic T cells in routinely fixed and paraffin-embedded tissue sections.
Wieczorek R; Buck D; Bindl J; Knowles DM
Hum Pathol; 1988 Dec; 19(12):1434-43. PubMed ID: 2973429
[TBL] [Abstract][Full Text] [Related]
15. Leu M-1 antigen: comparative expression in Hodgkin's disease and T cell lymphoma.
Strauchen JA; Breakstone B
Hematol Oncol; 1987; 5(2):107-14. PubMed ID: 2885252
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity of anti-Leu-M1 as a marker in Hodgkin's disease.
Frierson HF; Innes DJ
Arch Pathol Lab Med; 1985 Nov; 109(11):1024-8. PubMed ID: 3840354
[TBL] [Abstract][Full Text] [Related]
17. Expression of a Hodgkin and Reed-Sternberg cell associated antigen (Ki-1) in cutaneous lymphoid infiltrates.
Ralfkiaer E; Bosq J; Gatter KC; Schwarting R; Gerdes J; Stein H; Mason DY
Arch Dermatol Res; 1987; 279(5):285-92. PubMed ID: 2820316
[TBL] [Abstract][Full Text] [Related]
18. Lymphoblastic lymphoma: an immunophenotype study of 26 cases with comparison to T cell acute lymphoblastic leukemia.
Weiss LM; Bindl JM; Picozzi VJ; Link MP; Warnke RA
Blood; 1986 Feb; 67(2):474-8. PubMed ID: 3080041
[TBL] [Abstract][Full Text] [Related]
19. alpha-Naphthyl acetate esterase activity--a cytochemical marker for T lymphocytees. Correlation with immunologic studies of normal tissues, lymphocytic leukemias, non-Hodgkin's lymphomas, Hodgkin's disease, and other lymphoproliferative disorders.
Pinkus GS; Hargreaves HK; McLeod JA; Nadler LM; Rosenthal DS; Said JW
Am J Pathol; 1979 Oct; 97(1):17-41. PubMed ID: 315166
[TBL] [Abstract][Full Text] [Related]
20. Leu-22: a preferential marker for T-lymphocytes in paraffin sections. Staining profile in T- and B-cell lymphomas, Hodgkin's disease, other lymphoproliferative disorders, myeloproliferative diseases, and various neoplastic processes.
Said JW; Stoll PN; Shintaku P; Bindl JM; Butmarc JR; Pinkus GS
Am J Clin Pathol; 1989 May; 91(5):542-9. PubMed ID: 2785753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
